Observational Study
Copyright ©The Author(s) 2021.
World J Clin Oncol. Jan 24, 2021; 12(1): 13-30
Published online Jan 24, 2021. doi: 10.5306/wjco.v12.i1.13
Table 1 Characteristics of histhopathologic and status of ataxia-telangiectasia mutated polymorphism (D1853N) in patients with brain tumors
Patient ID
Age in yr
Histopath/grade
Other complications
D1853N polymorphism status
146Meningiotheliomatous type-+
247Meningioma/I--
334Meningothelial type-+
440Meningiotheliomatous type Focal micro-invasion to the underlying brain tissue +
537Meningioma/angiomatous --
666Meningothelial type --
756Meningothelial type-
850Meningiotheliomatous type--
921Meningiotheliomatous type/I --
1069Meningiotheliomatous type/I -+
1143Meningioma/transitional type--
1269Meningiotheliomatous type/I --
1349MeningiomaThyroid tumor (at the same age)+
1436Meningioma/atypical--
1550Metastatic carcinoma Primary site: Lung+
1651Metastatic brain Primary site: Breast+
1753Metastatic brain-breast origin Primary site: Breast+
1839Cerebellar medulloblastoma/IV Micro-vascular proliferation +